Cited by 137Radiomics and Machine Learning in Medical ImagingMRI in cancer diagnosisAI in cancer detection

Multimodal deep learning models for the prediction of pathologic response to neoadjuvant chemotherapy in breast cancer

Open access
Joo, Sunghoon, Ko, Eun Sook, Kwon, Soonhwan, Jeon, Eunjoo, Jung, Hyungsik, Kim, Ji-Yeon, Chung, Myung Jin, Im, Young-Hyuck·2021·Scientific Reports

Abstract

The achievement of the pathologic complete response (pCR) has been considered a metric for the success of neoadjuvant chemotherapy (NAC) and a powerful surrogate indicator of the risk of recurrence and long-term survival. This study aimed to develop a multimodal deep learning model that combined clinical information and pretreatment MR images for predicting pCR to NAC in patients with breast cancer. The retrospective study cohort consisted of 536 patients with invasive breast cancer who underwent pre-operative NAC. We developed a deep learning model to fuse high-dimensional MR image features and the clinical information for the pretreatment prediction of pCR to NAC in breast cancer. The proposed deep learning model trained on all datasets as clinical information, T1-weighted subtraction images, and T2-weighted images shows better performance with area under the curve (AUC) of 0.888 as compared to the model using only clinical information (AUC = 0.827, P < 0.05). Our results demonstrate that the multimodal fusion approach using deep learning with both clinical information and MR images achieve higher prediction performance compared to the deep learning model without the fusion approach. Deep learning could integrate pretreatment MR images with clinical information to improve pCR prediction performance.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-021-98408-8

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Joo, S., Ko, E. S., Kwon, S., Jeon, E., Jung, H., Kim, J.-Y., Chung, M. J., & Im, Y.-H.
Affiliations
  • Samsung (South Korea) (KR)
  • Samsung Medical Center (KR)
Corresponding author
Im, Young-Hyuck
Venue
Scientific Reports
Published
2021-09-22
Volume
11
Issue
1
Pages
18800-18800
ISSN
2045-2322 (ISSN-L)
OpenAlex
W3199109277
Cited by
137
References
42
Citations by year
2026: 20 · 2025: 41 · 2024: 39 · 2023: 28 · 2022: 9
FWCI
10.04
Type
journal article
Language
en
Open access
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Samsung (SMX1210791)
Topics
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiomics and Machine Learning in Medical Imaging
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › MRI in cancer diagnosis
  • Physical Sciences › Computer Science › Artificial Intelligence › AI in cancer detection
Keywords
breast cancer, neoadjuvant chemotherapy, pathological complete response, multimodal deep learning, pre-treatment MRI, T2-weighted imaging, treatment response prediction
MeSH terms
Deep Learning, Adult, Breast, Breast Neoplasms, Female, Humans, Magnetic Resonance Imaging, Middle Aged, Retrospective Studies, ROC Curve, Treatment Outcome, Neoadjuvant Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review